Saturday, December 3, 2022

Jack Wang Ph.D. Appointed to Pressao Medical BOD: An Accomplished Business Leader

Jack Wang, Ph.D. has been appointed to the Board of Directors of Pressao Medical. Wang is an accomplished business leader with more than 20 years’ experience in the medical device industry (including Biosensors International, Johnson & Johnson and Guidant Corporation) with a successful track record in business execution and exits.

Currently, Jack is the chairman and CEO of HeMo Bioengineering Limited, a medical device company established in 2017, primarily focusing on neurovascular intervention in Asia, with its current manufacturing and marketing and sales headquarters in China. Previously, Jack was the CEO of Biosensors International, a pioneer in interventional cardiology devices, where he was responsible for the company’s significant growth and strategic direction leading to the acquisition of several successful companies.

A graduate of Case Western Reserve University, Jack has been granted more than 20 U.S. and European patents in medical devices and technology and has published more than 30 scientific papers on polymer materials and processing.

“We are excited to welcome Dr. Jack Wang to our board. His unique combination of vast industry experience and perspective will be critical as we prepare for international market entry,” says Shawn Moaddeb, the chairman of Pressao Medical.

Subscribe To Medical Device News Magazine

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

Bone Health Technologies announces positive Topline Results from Groundbreaking Pivotal Trial of Non-pharmacological Treatment for Osteopenia

The trial by Bone Health Technologies was conducted in partnership with Laura Bilek, Ph.D., the Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC) and expert in clinical research for the treatment of low bone mass.

Covalon’s SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children’s Hospital

Jeremy Harman, PA-C, an author of the study, commented, "The trifecta of breathable barrier protection, antimicrobials, and the ability to monitor the site is what makes this a great dressing. It's easier for us to assess the wound and is more comfortable for patients."

Verve Medical Announces Results of Feasibility Trial for Transurethral Renal Pelvic Denervation for Uncontrolled Hypertension

The results of the Verve study were published last week in the American Heart Association’s (“AHA”) Hypertension journal. Hypertension is the leading risk factor for preventable deaths worldwide. See link to AHA publication below: (www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.122.20048).

By using this website you agree to accept Medical Device News Magazine Privacy Policy